SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is experiencing significant attention as traders anticipate a potential price breakout, frequently drawing comparisons to Zcash's recent performance and supply dynamics. While some investors remain bullish on the privacy coin narrative and potential technical reversals, others express frustration with recent price volatility and lack of sustained upward momentum.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is facing significant skepticism and selling pressure as investors express frustration over its long-term price decline and perceived lack of institutional demand. While some community members remain optimistic, highlighting network developments and potential future supply cap changes, many are calling the asset a "dead project" and advocating for rotation into other cryptocurrencies.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is seeing significant momentum as traders react to the ongoing parabolic rally, with many speculating that the asset will continue to reach higher milestones as it benefits from altcoin rotation and a strong privacy narrative. The conversation is heavily focused on bullish sentiment and community comparisons to Bitcoin, though some traders urge caution regarding potential volatility and profit-taking.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath shares experienced extreme volatility following a financial report that featured a revenue beat and raised guidance, though the initial upward momentum was tempered by concerns over growth metrics and competitive pressures. The community remains divided, with long-term investors pointing to strong cash flows and AI-driven potential as reasons to accumulate, while short-term traders debate whether the stock is undergoing a manipulative shakeout or facing fundamental stagnation.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is receiving attention as traders debate the sustainability of its recent rally amidst conflicting signals regarding regional geopolitical tensions and rising fuel costs. While some investors remain bullish on travel demand and potential margin expansion, others are initiating short positions or buying puts, citing concerns over high debt loads and the sensitivity of the company's operating margins to energy price fluctuations.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and volume following its listing on the Upbit exchange, which has driven significant community interest and speculation regarding its future price movement. While some traders view the new listing and infrastructure updates as catalysts for institutional adoption, others remain skeptical, dismissing the activity as another transient pump-and-dump cycle typical of the asset's history.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The conversation is highly fragmented, with participants engaging in intense political arguments, personal attacks, and debating various social and economic issues. There is no consensus-driven, market-related catalyst dominating the discussion, as sentiment is characterized by extreme polarization and off-topic commentary.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Investors are monitoring the stock's recent price volatility and trading volume as they weigh a mixed backdrop of strong financial performance, including record quarterly profits, against concerns over credit risk and institutional selling pressure. Sentiment remains divided between long-term confidence in the company's growth in Latin America and the U.S. and frustration with the asset's recent underperformance.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Investors are focused on the patent settlement with Teva Pharmaceuticals, which confirmed the validity and enforceability of key patents for the company's lead drug, fueling speculation about potential additional settlements with other generic manufacturers and a future buyout. While some traders express frustration with the company's lack of transparent communication and stagnant stock price, many view the litigation progress as a significant de-risking catalyst.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is gaining attention as traders monitor the company's progress toward a year-end NDA submission and potential regulatory approval for its psilocybin-based treatment. Investors are closely watching upcoming earnings and management commentary, with ongoing discussion regarding the company's valuation, competitive positioning, and the broader outlook for the psychedelic sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UNCY INVESTOR ALERT: Securities Class Action Filed Against Unicycive Therapeutics, Inc. Investors Encouraged to Contact Kirby McInerney LLP

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Unicycive Therapeutics (Unicycive or the Company) (NASDAQ: UNCY) securities during the period of December 29, 2025 through June 29, 2026, inclusive (the Class Period...

Law Offices of Howard G. Smith Encourages Unicycive Therapeutics, Inc. (UNCY) Shareholders To Inquire About Securities Fraud Class Action

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) common stock between December 29, 2025 and June 29, 2026, inclusive (the Class Period). Unicycive...

Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Securities Class Action

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities between December 29, 2025 and June 29, 2026. Unicycive is a clinical-stage...

UNCY CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Unicycive Therapeutics, Inc. Investors

Glancy Prongay Wolke & Rotter LLP (GPWR), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Patel v. Unicycive Therapeutics, Inc. et al., Case No. 25-cv-09559, on behalf of persons and entities that purchased or...

UNCY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Unicycive Therapeutics, Inc.

The law firm of Kirby McInerney LLP continues its investigation on behalf of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ:UNCY) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws and other unlawful business...

Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) investors concerning the Companys possible violations of the federal...

Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) investors concerning the Companys possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN UNICYCIVE THERAPEUTICS, INC...

Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) on behalf of investors concerning the Companys possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON UNICYCIVE THERAPEUTICS, INC...

UNICYCIVE THERAPEUTICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

The law firm of Kirby McInerney LLP is investigating potential claims against Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ:UNCY). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other...

UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval

Equity

Unicycive Therapeutics said on Tuesday that the U.S. Food and Drug Administration has again refused to approve its drug oxylanthanum carbonate. 


This account has been verified as an official UNCY representative.

Verified Account

Sara Frederick

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Bullish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Current Price	$5.16
Prev Close	$5.30
Open	$5.24
Dividend Yield	0.00%
50-Day Moving Average	$5.37
Beta	0.88
Avg. Volume	721,194.50
PE Ratio	-3.23

52-Week High	$8.74
52-Week Low	$3.71
Market Capitalization	$147.63M
EPS (Annual)	-$1.67
Price to Book	2.70
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

UNCY Fundamentals